HIV Vaccine Trial to Begin in South Africa

A new clinical trial is underway in South Africa on an experimental vaccine that could safely prevent HIV, the virus that causes AIDS. According to a statement from the National Institutes of Health (NIH), the HVTN 702 is the largest and most advanced HIV vaccine clinical trial to be undertaken in South Africa, where some seven million people are living with the virus. The director of the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the NIH, Anthony...

© La Voix de l'Amérique - dimanche 27 novembre 2016